Close Menu

Testing a lung tumor's genome for alterations is helping patients get treatments matched to their disease, US News & World Report says.

About 60 percent of lung adenocarcinomas harbor specific gene mutations that may be key drivers of disease, it says, adding that by targeting these changes, clinicians may be better able to treat the disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.